Company intelligence / Profile preview

Biostime

Ownership: Private
Development stage: Other

Overview

Biostime is a leading brand in children's probiotics and premium pediatric nutrition with over two decades of scientific research. It holds significant market share in China’s children’s probiotic supplements and infant formula markets. The company has expanded globally through strategic acquisitions such as Swisse Wellness Group to broaden its portfolio into adult supplements.

Modalities: Probiotic supplementInfant formulaNutritional supplement
Industry: Food & Nutrition

Partnerships

PGT Healthcare LLP

Beyond the preview

Go deeper on Biostime.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biostime.

Explore the full profile